Fractyl Health faces Nasdaq delisting risk after failing $1 minimum bid rule

A requested hearing would automatically stay any suspension or delisting, keeping the stock trading during the review.

Compliance requires a closing bid of at least $1 for 10 consecutive business days, up to 20 at Nasdaq’s discretion.

A proxy filed Aug. 24, 2026 seeks shareholder approval for a 1-for-5 to 1-for-15 reverse stock split.

Fractyl Health faces potential Nasdaq delisting for failing the $1 minimum bid-price rule under Listing Rule 5450(a)(1).

Nasdaq issued a delisting notice dated Sept. 10, 2026, following a 180-day compliance window that ended Sept. 9, 2026.